Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hadoux

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid TumorsPatrick Robelin, Julien Hadoux, Julien Forestier, et al.
Cancers|May 14, 2022
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall SurvivalSegolene Hescot, Matthieu Faron, Manal Kordahi, et al.
Journal of the Endocrine Society|June 10, 2024
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors GroupBenjamin Chevalier, Delphine Bonnet, Come Lepage, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2017
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoidsIvana Sullivan, Gwénaël Le Teuff, Joël Guigay, et al.
Endocrine|August 28, 2023
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational studyFrancisca Marques Puga, Abir Al Ghuzlan, Dana M Hartl, et al.
Thyroid : Official Journal of the American Thyroid Association|March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib TreatmentSophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
Neuroendocrinology|October 23, 2019
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?Julien Hadoux, Pierre Blanchard, Jean-Yves Scoazec, et al.
Thyroid : Official Journal of the American Thyroid Association|October 29, 2025
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant MetastasesTommaso Porcelli, Sophie Moog, Mohamed-Amine Bani, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2023
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case ReportsSophie Moog, Livia Lamartina, Mohamed-Amine Bani, et al.
Hormones & Cancer|July 28, 2017
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma PatientsJulien Hadoux, Marie Terroir, Sophie Leboulleux, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 17, 2019
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid TumorsPatrick Robelin, Julien Hadoux, Julien Forestier, et al.
Cancers|May 14, 2022
Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall SurvivalSegolene Hescot, Matthieu Faron, Manal Kordahi, et al.
Journal of the Endocrine Society|June 10, 2024
Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors GroupBenjamin Chevalier, Delphine Bonnet, Come Lepage, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2017
Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoidsIvana Sullivan, Gwénaël Le Teuff, Joël Guigay, et al.
Endocrine|August 28, 2023
Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational studyFrancisca Marques Puga, Abir Al Ghuzlan, Dana M Hartl, et al.
Thyroid : Official Journal of the American Thyroid Association|March 19, 2019
Redifferentiation of a <i>BRAF</i>-Mutated Poorly Differentiated Thyroid Cancer Patient with Dabrafenib and Trametinib TreatmentSophie Leboulleux, Corinne Dupuy, Ludovic Lacroix, et al.
Neuroendocrinology|October 23, 2019
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?Julien Hadoux, Pierre Blanchard, Jean-Yves Scoazec, et al.
Thyroid : Official Journal of the American Thyroid Association|October 29, 2025
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant MetastasesTommaso Porcelli, Sophie Moog, Mohamed-Amine Bani, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2023
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case ReportsSophie Moog, Livia Lamartina, Mohamed-Amine Bani, et al.
Hormones & Cancer|July 28, 2017
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma PatientsJulien Hadoux, Marie Terroir, Sophie Leboulleux, et al.
Pageof 12